Head OfficeNovartis International AGCH-4002 BaselSwitzerland
+41 61 324 11 11+41 61 324 80 01Monday - Friday,8:30 - 17:00, GMT+1(Central European Time)
More information
Novartis International AGInvestor RelationsP.O. BoxCH-4002 BaselSwitzerland
+41 61 324 79 44investor.relations@novartis.com
Global Media RelationsEric AlthoffBasel, Switzerland
+41 61 324 7999eric.althoff@novartis.com
Track the recent performance of Novartis shares on the SIX Swiss Exchange and Novartis American Depositary Shares (ADSs) on the New York Stock Exchange (NYSE).
Back to top
Alcon information center
Pharmaceutical products
Clinical pipeline
Management bios
December 13 oncology call presentation (1.9 MB)
Form 20-F 2011 (2.0 MB)
Corporate organizational structure (41 KB)
Stock performance
Novartis announced its results for the first quarter of 2012 on April 24 ยป